Orvepitant Maleate

DRUG2 trials

Sponsors

Nerre Therapeutics Ltd.

Conditions

Chronic Refractory CoughCoughIdiopathic Pulmonary Fibrosis

Phase 2

A Dose-ranging Study of Orvepitant in Patients With Chronic Refractory Cough

CompletedNCT02993822

Nerre Therapeutics Ltd.Chronic Refractory Cough

Start: 2017-05-22End: 2019-01-24Updated: 2022-04-26

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

CompletedNCT05185089

Nerre Therapeutics Ltd.Cough, Idiopathic Pulmonary Fibrosis

Start: 2022-08-01End: 2024-06-19Updated: 2025-11-10